Delivery Order SPE2DB22D3401-SPE2DB25FT5NB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, with a ceiling value of $1,108.54. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, representing a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, with a ceiling value of $4,226.30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,225.07 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ivermectin 1% cream (45 gm). This delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ivermectin tablets, with a contract ceiling value of $2,185.96 and a completion deadline of August 22, 2025. The award, issued on August 21, 2025, represents a firm fixed-price delivery order utilizing no set-aside provisions, indicating the contract was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.56 Firm Fixed Price Delivery Order is for the supply of 4566602576 Ivermectin 1% Cream, 45GM. The award has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $2,421.54 to AmerisourceBergen Drug Corp for the supply of Ivermectin 3 mg tablets in unit dose packaging of 20 count on September 22, 2025, with a completion date of September 23, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% Cream 45GM, with a ceiling value of $5,153.25 and a completion date of May 13, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFLMZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ivermectin 1% cream 45g. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $1,089.69. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Ivermectin 1% cream (45g) to the Defense Logistics Agency (DLA). The $1,330.56 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ivermectin 1% Cream 45GM, a medication, with a firm fixed price ceiling value of $2,602.62 and a performance period through May 22, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5NBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ivermectin 1% Cream in 45-gram units, with a ceiling value of $3,044.73 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through competitive procurement with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as part of its comprehensive pharmaceutical support to military and veteran healthcare systems. The company's extensive federal contracting portfolio with the DLA demonstrates its capability to meet diverse medical supply requirements across multiple therapeutic domains, including specialty medications, generic drugs, and specialized medical commodities. The ultimate completion date for this delivery order is August 7, 2025, reflecting the expedited nature typical of individual line items under the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/6/25 |